Dolasetron

When and How to Take It

General considerations for when and how to take dolasetron include the following:
 
  • This medication comes in tablet form. It is taken by mouth, usually within one hour before chemotherapy or within two hours before surgery.
     
  • Dolasetron also comes in an injectable form that is given by an IV. An injection can also be taken by mouth (when mixed with apple or apple-grape juice). This is useful for children who cannot swallow tablets, or who need a smaller dose than is available in tablet form.
     
  • Dolasetron can be taken with or without food. However, you may need to have an empty stomach for surgery. Be sure to ask your healthcare provider if you may take your dose with food.
     
  • For the medication to work properly, it must be taken as prescribed.
     

Dosing Information

The dose of dolasetron your healthcare provider recommends will vary, depending on a number of factors, including:
 
  • If you are having surgery or chemotherapy
  • Your age and weight
  • Other medications you may be taking
  • Other medical conditions you may have.
     
As is always the case, do not adjust your dose unless your healthcare provider specifically instructs you to do so.
 
(Click Dolasetron Dosing for more information.)
 

Dolasetron Side Effects

As with any medicine, side effects are possible with dolasetron. However, not everyone who takes the drug will experience problems. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider. Serious reactions are less common.
 
Common side effects of dolasetron include but are not limited to:
 
(Click Side Effects of Dolasetron to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 
(Dolasetron Continued: Page 3)
Pages:

Previous 1 2 3 4 Next

Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation